Profound Medical Corp. 8-K

What Happened Profound Medical Corp. (PROF) announced in an 8-K (Regulation FD disclosure) on February 12, 2026, that it plans to release its fourth quarter and full‑year 2025 financial results after market close on Thursday, March 5, 2026. The company will host a conference call and webcast to review the results and discuss business developments at 4:30 p.m. Eastern Time the same day. A press release with call/webcast access details was furnished as Exhibit 99.1.

Key Details

• Announcement date: February 12, 2026 (8-K filed under Item 7.01 — Regulation FD Disclosure).
• Results to be released: Fourth quarter and full year 2025, after market close on Thursday, March 5, 2026.
• Conference call/webcast: Scheduled for March 5, 2026 at 4:30 p.m. Eastern Time; access information provided in the company press release (Exhibit 99.1).
• Form signed by: Rashed Dewan, Chief Financial Officer, on behalf of the company.

Why It Matters This notice sets the timing for Profound Medical’s next earnings announcement and investor call — important dates for shareholders, analysts, and potential investors who follow the company’s quarterly and annual financial performance. The conference call and webcast provide an opportunity to hear management’s commentary on revenue, profitability, guidance, and recent business developments when the results are released.